tags

CIRS will be exhibiting at the China Beauty Expo, taking place in Shanghai, China, between May 12-14, 2026.

In March 2026, the Shanghai Municipal, Fujian Provincial, Hubei Provincial, and Anhui Provincial Medical Products Administrations successively issued announcements regarding cosmetic supervision and sampling inspections. A total of 12 batches of products were found to be non-compliant. This summary of the announcements aims to help enterprises stay informed of evolving regulatory trends and strengthen their quality management and compliance awareness.

From March 18 to 20, 2026, the three-day PCHi exhibition came to a successful close at the Hangzhou International Convention and Exhibition Center. As a key event in the global cosmetics, personal care, and home care industries, this year’s show brought together numerous leading domestic and international enterprises and industry elites.

CIRS is delighted to announce that we will be exhibiting at the PCHi in Hangzhou, China between 18-20 March, 2026.

On January 15, 2025, China’s National Institutes for Food and Drug Control (NIFDC) issued a notice announcing the release of three draft cosmetic standards aimed at further enhancing the country’s technical framework for cosmetics. The drafts are now open for public consultation, with the deadline for submitting comments set for February 24, 2026.

This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of November 2025, covering industry news, newly issued regulations, latest standards updates, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.

Per- and polyfluoroalkyl substances (PFAS) are increasingly becoming a focal point of global concern due to their potential long-term impacts on the environment and human health. As a class of synthetic chemicals characterized by high stability and widespread applications, PFAS are facing increasingly stringent regulatory scrutiny in the cosmetics sector. This article explores the physicochemical properties and potential health risks of PFAS, and systematically reviews the evolving global regulatory landscape related to their use in cosmetics. It aims to help cosmetic enterprises gain a comprehensive understanding of regulatory requirements, mitigate compliance risks, enhance product safety, and strengthen competitiveness in international markets.

This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of October 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.

This article provides a consolidated overview of the relevant regulatory notices, supplemented by recent developments in regulatory enforcement activities-such as unannounced inspections and sampling inspections-conducted by the National Medical Products Administration (NMPA) and selected provincial and municipal authorities. The aim is to assist enterprises in staying informed of evolving regulatory trends and to reinforce awareness of quality management and compliance requirements.

In our last article, Is Your Scalp Healthy? – Scalp Health Evaluation Methods (Part I), we have introduced the evaluation methods for dandruff, sebum levels, and itchiness. In this article, we will continue with the evaluation methods for erythema/papules/pustules and the overall hair status.